Evidence map›Paper›PMID 42730232›Full record

ArticleQualitative research in medicine & healthcare2026

Perspectives on Lyme disease among persons of color in the United States: Qualitative research findings.

Stephanie A Duench, L Hannah Gould, Alexandra Kissling, Kathleen Beusterien, Lewis Kopenhafer, Gabriela Burgos

Abstract read
In one paragraph

Article in Qualitative research in medicine & healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stephanie A DuenchUS Medical Affairs, US Commercial Division, Pfizer, Collegeville, PA, USA.
L Hannah GouldGlobal Vaccines and Antivirals Medical Affairs, US Commercial Division, Pfizer, New York, NY, USA.
Alexandra KisslingOracle Life Sciences, Austin, TX, USA.
Kathleen BeusterienOracle Life Sciences, Austin, TX, USA.
Lewis KopenhaferOracle Life Sciences, Austin, TX, USA.
Gabriela BurgosOracle Life Sciences, Austin, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Lyme disease is the most common vector-borne illness in the United States, with an estimated 476,000 cases diagnosed and treated annually. Although incidence is highest among White individuals, people of color are more likely to experience severe or disseminated manifestations. This study explored factors contributing to this disparity by examining experiences of people of color diagnosed with Lyme disease. Setting: Participants resided in high-incidence U.S. states. Participants: Self-identified people of color diagnosed with Lyme disease within the past 12 months. Methods: Fifteen participants completed in-depth interviews analyzed using inductive and deductive qualitative content analysis. Follow-up focus groups supported consensus-building and thematic refinement. Results: Key themes included limited awareness that people of color are at risk for Lyme disease, perceived discrimination in healthcare encounters, diagnostic delays attributed to the characteristic erythema migrans (EM) rash being less visible on darker skin, and insufficient physician knowledge regarding diverse clinical presentations. Participants also expressed a preference for racially concordant providers. Lyme disease affected physical health, emotional well-being, social relationships, and engagement in outdoor activities. Conclusions: People of color may face distinct challenges in Lyme disease recognition and management, contributing to disparities in outcomes. Findings underscore the need for targeted education for at-risk populations, patients, and providers and for equitable prevention and diagnostic strategies.

Indexed as

DiscriminationHealth disparitiesLyme diseasePatient experiences

Identifiers

PMID42730232
PMCPMC13564120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.